Literature DB >> 8629300

An analysis of late deaths after liver transplantation.

S Asfar1, P Metrakos, J Fryer, D Verran, C Ghent, D Grant, M Bloch, P Burns, W Wall.   

Abstract

Late deaths (after more than 1 year) after liver transplantation were analyzed in a series of 464 consecutive patients who received liver grafts between 1982 and 1993. Recipients who survived the first posttransplant year (n = 365) had actuarial 5- and 10-year survival rates of 92% and 84%, respectively. Thirty-five patients died between 1.1 and 7.6 years after transplantation (mean, 3.2 +/- 1.9 years). The most common causes of death were related to immunosuppression (40%), namely, chronic rejection, opportunistic infection, and lymphoma. The second most common causes of death were related to the primary disease for which liver transplantation was performed (34.3%), mainly recurrence of hepatobiliary malignancy and hepatitis B. Eight patients (22.9%) died of unrelated and unpredicted causes, most commonly of cardiovascular disease. Although the survival of liver recipients who live beyond the first posttransplant year is excellent, control of rejection and the consequences of chronic immunosuppression are continual threats. Modification of immunosuppression may help in decreasing the mortality of long-term survivors. In addition, better selection of recipients and effective adjuvant therapies (antiviral and antineoplastic) are needed in patients in whom the primary liver disease is notorious for recurrence.

Entities:  

Mesh:

Year:  1996        PMID: 8629300     DOI: 10.1097/00007890-199605150-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

1.  High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation.

Authors:  Francisco Boix-Giner; Olga Millan; David San Segundo; Pedro Muñoz-Cacho; Esther Mancebo; Santiago Llorente; Lourdes Rafael-Valdivia; Antoni Rimola; Emilio Fábrega; Anna Mrowiec; Luis Allende; Alfredo Minguela; Jose M Bolarín; Estela Paz-Artal; Marcos López-Hoyos; Mercé Brunet; Manuel Muro
Journal:  Int Immunol       Date:  2015-08-12       Impact factor: 4.823

2.  Biliary strictures after liver transplantation.

Authors:  Choong Heon Ryu; Sung Koo Lee
Journal:  Gut Liver       Date:  2011-06-23       Impact factor: 4.519

3.  Long-term survival after liver transplantation in 4,000 consecutive patients at a single center.

Authors:  A Jain; J Reyes; R Kashyap; S F Dodson; A J Demetris; K Ruppert; K Abu-Elmagd; W Marsh; J Madariaga; G Mazariegos; D Geller; C A Bonham; T Gayowski; T Cacciarelli; P Fontes; T E Starzl; J J Fung
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

Review 4.  Immune monitoring post liver transplant.

Authors:  Siddharth Sood; Adam G Testro
Journal:  World J Transplant       Date:  2014-03-24

5.  Evaluation of liver transplant recipients.

Authors:  Paul J Thuluvath
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

6.  Association of preoperative parameters with postoperative mortality and long-term survival after liver transplantation.

Authors:  Dionisios Vrochides; Mazzen Hassanain; Jeffrey Barkun; Jean Tchervenkov; Steven Paraskevas; Prosanto Chaudhury; Marcelo Cantarovich; Marc Deschenes; Phil Wong; Peter Ghali; Gabriel Chan; Peter Metrakos
Journal:  Can J Surg       Date:  2011-04       Impact factor: 2.089

7.  Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats.

Authors:  R Mehvar; D A Hoganson
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

Review 8.  Options for induction immunosuppression in liver transplant recipients.

Authors:  Michael A J Moser
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Liver transplantation.

Authors:  Deok-Bog Moon; Sung-Gyu Lee
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

10.  Liquid chromatography-tandem mass spectrometry for the determination of methylprednisolone in rat plasma and liver after intravenous administration of its liver-targeted dextran prodrug.

Authors:  Shuang-Qing Zhang; Helen R Thorsheim; Suman Penugonda; Venkateswaran C Pillai; Quentin R Smith; Reza Mehvar
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-02-21       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.